Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

UNQ9438 Activators

The modulation of intracellular signaling pathways through various biochemical mechanisms is integral to the activation of UNQ9438. For instance, the elevation of cyclic AMP (cAMP) within the cellular milieu is a potent trigger for the activation of protein kinase A (PKA), a kinase known to play a pivotal role in the phosphorylation of target proteins. This biochemical cascade is initiated by compounds that directly stimulate adenylate cyclase or by cAMP analogs, ultimately leading to the phosphorylation of key serine and threonine residues on proteins, thereby potentially enhancing the functional activity of UNQ9438. Similarly, the activation of protein kinase C (PKC) through certain diacylglycerol analogs represents another pathway by which this protein's activity may be amplified. By increasing the phosphorylation status of proteins within the signaling network, PKC activators could facilitate the activation of UNQ9438 by promoting conformational changes or altering its interaction with other mitochondrial proteins.

Additionally, the intricate balance of intracellular calcium levels is a critical determinant of UNQ9438's activation state. Calcium-mobilizing agents and ionophores that perturb the calcium equilibrium within the cell can stimulate calcium-sensitive signaling pathways, often involving calmodulin or other calcium-binding proteins, which could lead to the activation of UNQ9438. Furthermore, inhibitors of phosphatases such as protein phosphatase 1 and 2A indirectly foster a phosphorylated state of cellular proteins by preventing dephosphorylation, thereby maintaining the proteins in an active form, which may include UNQ9438. Intriguingly, compensatory cellular responses to calcium chelation also play a role, as they can trigger calcium-dependent signaling pathways that might upregulate the activity of UNQ9438.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels, which can enhance the activity of UNQ9438 by fostering protein kinase A (PKA)-mediated phosphorylation.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Activates protein kinase C (PKC), which could phosphorylate and activate UNQ9438 as part of downstream signaling.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Increases intracellular calcium concentration, potentially promoting the calcium-dependent activation of UNQ9438 through calmodulin-dependent pathways.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Non-selective inhibitor of phosphodiesterases, leading to increased cAMP levels that could enhance UNQ9438 activity via PKA-mediated signaling pathways.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$97.00
$224.00
30
(1)

cAMP analog that activates PKA, potentially leading to the phosphorylation and activation of UNQ9438.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

Calcium ionophore that raises intracellular calcium levels, possibly promoting the activation of UNQ9438 via calcium-sensitive signaling pathways.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$45.00
$130.00
$480.00
$4450.00
74
(7)

Membrane-permeable cAMP analog that activates PKA, which may subsequently activate UNQ9438 by phosphorylation.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$285.00
$520.00
$1300.00
78
(4)

Inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels and possibly enhanced activity of UNQ9438.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

Beta-adrenergic agonist that increases cAMP levels, potentially leading to PKA activation and subsequent activation of UNQ9438.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits phosphatidylinositol 3-kinases (PI3K), which may indirectly activate UNQ9438 by altering downstream AKT signaling and modulating mitochondrial dynamics.